scholarly journals Incipient Non-Arteritic Anterior Ischemic Optic Neuropathy in a Patient with Metastatic Small-Cell Lung Cancer

2021 ◽  
pp. 513-518
Author(s):  
Arshia Eshtiaghi ◽  
Jonathan A. Micieli

A 70-year-old woman with metastatic small-cell lung cancer was referred for isolated left optic disc edema that was incidentally discovered. She had normal visual function, and dilated fundus examination revealed a small, cupless optic nerve in the right eye and moderate optic disc edema in the left eye. Magnetic resonance imaging (MRI) of the orbits with contrast was normal, and MRI brain and magnetic resonance venography were normal without signs of raised intracranial pressure. Lumbar puncture showed a normal opening pressure and normal cerebrospinal fluid contents. A diagnosis of incipient non-arteritic anterior ischemic optic neuropathy (NAION) was made, and the optic disc edema resolved after 4 months. Incipient NAION is an uncommon cause of unilateral optic disc edema with preserved visual function and is a diagnosis of exclusion. In diagnosing incipient NAION, other causes of optic disc edema must first be ruled out. These alternative causes include papilledema, optic nerve sheath meningioma or other orbital masses, and vitreopapillary traction. Incipient NAION is thought to be caused by subclinical ischemia. This case indicates that incipient NAION may also occur in patients with metastatic cancer and is possibly related to their hypercoagulable state. Although there is no treatment once vision loss develops, the optimization of risk factors may prevent the progression of incipient NAION to classic NAION.

2019 ◽  
Vol 55 (1) ◽  
pp. 9-16 ◽  
Author(s):  
Tara Pereiro Brea ◽  
Alberto Ruano Raviña ◽  
Josèc) Martín Carreira Villamor ◽  
Antonio Golpe Gómez ◽  
Anxo Martínez de Alegría ◽  
...  

2005 ◽  
Vol 23 (14) ◽  
pp. 3203-3211 ◽  
Author(s):  
Lalitha K. Shankar ◽  
Daniel C. Sullivan

Accurate detection of the presence and extent of disease is vital in the management of non–small-cell lung cancer. While computed tomography and magnetic resonance imaging tend to be the routine diagnostic modalities used in the management of lung cancer, there have been significant advances in the field of functional and molecular imaging. In this article, we review the performance of the functional imaging techniques that are currently available for the evaluation of non–small-cell lung cancer. The techniques range from evaluation of glucose metabolism in tumors with fluorodeoxyglucose, to evaluation of proliferation with fluorothymidine and evaluation of tumor hypoxia with agents such as fluoromisonidazole. Magnetic resonance imaging with an emphasis on dynamic contrast enhancement of tumors as well as detecting of malignant lymph nodes with targeted contrast agents is discussed. Emerging technologies such as lung imaging fluorescence endoscopy are considered. The role of functional imaging in planning, predicting response to, and evaluating effects of, various therapies is explored.


2017 ◽  
Vol 34 (2) ◽  
pp. 115-124 ◽  
Author(s):  
Gang Yin ◽  
Churong Li ◽  
Heng Chen ◽  
Yangkun Luo ◽  
Lucia Clara Orlandini ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document